Bottom Line Here's what the data tells us: GI side effects dominate: nausea, diarrhea, vomiting, constipation Higher efficacy = slightly higher side effects at maximum doses Glucagon adds benefits: liver fat reduction, increased energy expenditure Slow escalation helps: 20+ week titration minimizes symptoms Still investigational: Phase 3 trials ongoing, FDA decision expected 2025-2026 Sources Retatrutide Phase 2 Trial (Jastreboff et al., NEJM 2023) TRIUMPH Phase 3 Trial (ClinicalTrials.gov) ClinicalTrials.gov Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice
Because the Glutathione element in the injection is an antioxidant, it assists in the clearance of toxins from the body by cleansing the skin and reducing dark spots, acne scars, and blemishes on the face
Across the reviews, there was little to no difference between these drugs and placebo for major cardiovascular events, quality of life, or mortality
Unlike the DAC-conjugated version, the no-DAC form lacks the albumin-binding linker and is studied as a short-acting GRF analog